USPTO 2015–2025 USPTO PatentsView US Corporation

Rehabilitation Institute of Chicago

USPTO PatentsView assignee record - 63 granted patents across 21 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

RSS updates for this company

The verdict

According to USPTO PatentsView, Rehabilitation ranks #5,463 of 49,997 tracked US assignees by granted-patent volume, with 63 patents across 21 technology areas.

#5,463
of 49,997 US assignees by volume
Top 27%
by Innovation Score (43.9/100)
17.5
avg claims per patent
-28%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R5463 · US Corporation #5,463 · 63 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL

  • GRANTS-SMALL 63 grants
  • UPPER-Q #5,463/49,997
  • PHOTO-FINISH Plexxikon
  • CPC-FOCUS A61F · 21 areas
  • INNOV-PAR 43.9/100
  • CLAIMS-RICH 17.5 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DOWN -28% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Plexxikon Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Rehabilitation’s 43.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Rehabilitation

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Rehabilitation's Innovation Score is 43.9/100 (top 27% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Rehabilitation?

Each dot is one of Rehabilitation’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Rehabilitation’s own 17.5 claims/patent is ABOVE the 11.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Rehabilitation vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 62.963.063.06363.063.063.1 05101520 Granted patents (volume) Avg claims / patent Plexxikon Inc. - 63, 16.35PlexxikonPureWick Corporation - 63, 17.6PurewickR A Brands L.L.C. - 63, 11.37R A Brands L L CRockspoon, Inc - 63, 11.46RockspoonRobert Bosch Automotive Steering LLC - 63, 11.75Robert Bosch Auto…Shanghai University - 63, 10.52Shanghai Universi…Shenzhen Eigate Technology Co., Ltd. - 63, 2.1Shenzhen Eigate T…SK Global Chemical Co., Ltd. - 63, 11.51SK Global ChemicalRehabilitation Institute of Chicago - 63, 17.52Rehabilitation In…
Rehabilitation vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Rehabilitation's grants concentrate

Rehabilitation Institute of Chicago is a focused PatentsView assignee: 21 CPC subclasses with 50.8% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2019 (18 grants) versus a trough of 1 in 2015. By volume, Rehabilitation sits between Plexxikon Inc. and SK Global Chemical Co., Ltd..

Rehabilitation's three-year grant acceleration

From 2019–2021 to 2022–2024, Rehabilitation Institute of Chicago moved from 31 to 13 grants (0.42x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Who files at Rehabilitation's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Rehabilitation holds 63 patents at rank #5,464, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Rehabilitation

By rank, the assignees closest to #5,464 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Rehabilitation's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Rehabilitation, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Rehabilitation ranks #197 of 3,082 assignees by patent count in that subclass.

Rehabilitation's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

44 Top 27% higher than 73% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

05101520 20152016201720182019202020212022202320242025 1
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Rehabilitation Institute of Chicago patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 1 1.6%
2016 1 1.6%
2017 11 17.5%
2018 5 7.9%
2019 18 28.6%
2020 9 14.3%
2021 4 6.3%
2022 6 9.5%
2023 3 4.8%
2024 4 6.3%
2025partial year 1 1.6%

Which technologies does Rehabilitation Institute of Chicago patent most?

Top 15 of 21 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Rehabilitation Institute of Chicago's patent record in context - here's where to go next.

  • Rehabilitation Institute of Chicago's lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 50.8% of its portfolio - see every assignee active in that class. Explore A61F
  • Ranked #5,463 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Rehabilitation Institute of Chicago against Plexxikon Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 43.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.